Tumor angiogenesis and recurrence in stage I non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 68, Issue 3, 1999, Pages 1034-1038

  Ohta, Yasuhiko ^a   Tomita, Yoshiharu ^a   Oda, Makoto ^a   Watanabe, Shunichi ^a   Murakami, Shinya ^a   Watanabe, Yoh ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; CANCER RECURRENCE; CANCER STAGING; CONFERENCE PAPER; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FACTOR VIII; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032742909     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00611-6     Document Type: Conference Paper

References (17)

1. Macchiarini P., Fontanini G., Hardin M.J., et al. Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet. 340:1992;145-146.
2. Yamazaki K., Abe S., Takekawa H., et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer. 74:1994;2245-2250.
3. Mattern J., Koomagi R., Volm M. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int J Oncol. 6:1995;1059-1062.
4. Chandrachud L.M., Pendleton N., Chisholm D.M., et al. Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer. 76:1997;1367-1375.
5. Folkman J., Watson K., Ingber D., et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61.
6. Skobe M., Rockwell P., Goldstein N., et al. Halting angiogenesis suppresses carcinoma cell invasion. Nat Med. 3:1997;1222-1227.
7. Watanabe Y., Shimizu J., Oda M., et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg. 51:1991;253-261.
8. Watanabe Y., Shimizu J., Tsubota M. Mediastinal spreads of metastatic lymph nodes in bronchogenic carcinoma. Chest. 97:1990;1059-1065.
9. Sobin L.H., Wittekind C. TNM classification of malignant tumours. 1997;Wiley-Liss, New York.
10. Ohta Y., Endo Y., Tanaka M., et al. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res. 2:1996;1411-1416.
11. Weidner N., Semple J.P., Welch W.R., et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 324:1991;1-8.
12. Fontanini G., Bigini S., Vignati S. Microvessel count predict metastatic disease and survival in non-small cell lung cancer. J Pathol. 177:1995;57-63.
13. Giatromanolaki A., Koukourakis M., O'Byrne K., et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol. 179:1996;80-88.
14. Berse B., Brown L.F., Water L.V.D., et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 3:1992;221-233.
15. Fontanini G., Vignati S., Boldrini L., et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res. 3:1997;861-865.
16. Volm M., Rittgen W., Drings P. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer. 77:1998;663-669.
17. Ohta Y., Watanabe Y., Murakami S., et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer. 76:1997;1041-1045.